QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 expedia-sandisk-and-penumbra-are-among-the-top-10-large-cap-gainers-last-week-nov-3-nov-7-are-the-others-in-your-portfolio

Expedia, SanDisk, and Penumbra led last week's large-cap gainers, with strong earnings and raised guidance fueling broad do...

 rbc-capital-maintains-outperform-on-globus-medical-raises-price-target-to-92

RBC Capital analyst Shagun Singh maintains Globus Medical (NYSE:GMED) with a Outperform and raises the price target from $88...

 wells-fargo-maintains-overweight-on-globus-medical-raises-price-target-to-79

Wells Fargo analyst Vik Chopra maintains Globus Medical (NYSE:GMED) with a Overweight and raises the price target from $66 t...

Core News & Articles

FIGS: 19% | FIGS shares are trading higher after the company reported better-than-expected Q3 financial results and issued FY25...

 b-of-a-securities-upgrades-globus-medical-to-buy-raises-price-target-to-91

B of A Securities analyst Craig Bijou upgrades Globus Medical (NYSE:GMED) from Neutral to Buy and raises the price target fr...

 truist-securities-upgrades-globus-medical-to-buy-raises-price-target-to-93

Truist Securities analyst Richard Newitter upgrades Globus Medical (NYSE:GMED) from Hold to Buy and raises the price target ...

 globus-medical-raises-fy2025-adj-eps-guidance-from-300-330-to-375-385-vs-321-est-raises-fy2025-sales-guidance-from-2800b-2900b-to-2860b-2900b-vs-2855b-est

Globus Medical (NYSE:GMED) raises FY2025 Adj EPS guidance from $3.00-$3.30 to $3.75-$3.85 vs $3.21 analyst estimate. Raises FY2...

 globus-medical-q3-adj-eps-118-beats-078-estimate-sales-769048m-beat-734347m-estimate

Globus Medical (NYSE:GMED) reported quarterly earnings of $1.18 per share which beat the analyst consensus estimate of $0.78 by...

 stifel-reinstates-hold-on-globus-medical-announces-64-price-target

Stifel analyst Thomas Stephan reinstates Globus Medical (NYSE:GMED) with a Hold and announces $64 price target.

 carlsmeds-personalized-spine-implants-get-significant-reimbursement-advantage

Carlsmed secures NTAP reimbursement and FDA support, while BofA projects strong revenue growth and assigns a Buy rating with a ...

 wells-fargo-maintains-overweight-on-globus-medical-lowers-price-target-to-66

Wells Fargo analyst Vik Chopra maintains Globus Medical (NYSE:GMED) with a Overweight and lowers the price target from $76 t...

 globus-medical-affirms-fy2025-adj-eps-guidance-of-300-330-vs-316-est-affirms-fy2025-sales-guidance-of-2800b-2900b-vs-2852b-est

Globus Medical (NYSE:GMED) affirms FY2025 Adj EPS guidance from $3.00-$3.30 to $3.00-$3.30 vs $3.16 analyst estimate. Affirms F...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION